Peripheral neuropathy Board decisions

The veteran's claim for secondary service connection for peripheral neuropathy of the bilateral upper extremities, a disorder of the left lower extremity, glaucoma, and bladder disorder is denied as there are no current diagnoses that support these claims.,The veteran's claim for secondary service connection for coronary artery disease (including hypertension) is denied as there is no evidence of such condition.

The veteran's appeal is being remanded for additional development, including obtaining Social Security Administration records and providing proper VCAA notice.

The Board found that the veteran does not have diabetic peripheral neuropathy and therefore denied his claim for service connection.

The Board has determined that the veteran does not have peripheral neuropathy in either his right upper or lower extremity, and finds that it is not related to his service-connected diabetes mellitus.

The Board has granted service connection for type II diabetes mellitus, bilateral peripheral neuropathy, erectile dysfunction, a facial scar, and fungal infection of the feet. The veteran is presumed to have been exposed to herbicides in Vietnam, which supports his claim for type II diabetes mellitus.

The Board granted increased disability evaluations for sensory neuropathy of the left upper and lower extremities, as well as right upper and lower extremities. The maximum schedular evaluation was assigned.

The veteran's diabetes mellitus and diabetic neuropathy of the lower extremities are currently rated at their maximum allowable levels, with no additional ratings granted.

The VA determined that the veteran's left shoulder and arm disability with associated neuropathy does not warrant a rating higher than 30 percent.

The Board has granted a 30 percent evaluation for PTSD, effective from September 19, 2003. The veteran's PTSD produces occupational and social impairment with occasional decrease in work efficiency and intermittent periods of inability to perform tasks.

The veteran's service-connected peripheral neuropathy of the right and left upper extremities has been rated at 10 percent since August 4, 2006. Prior to this date, he was granted a 10 percent rating for each affected extremity.

The veteran's claims for service connection for diabetes mellitus, peripheral neuropathy, hearing loss, and tinnitus related to exposure to Agent Orange are denied as there is no current evidence of these conditions.

The Board has determined that the veteran's service-connected peripheral neuropathy of each lower extremity results in disability tantamount to no worse than mild incomplete paralysis of the peripheral nerves, and thus does not warrant an increased rating.

The Board has remanded the case due to insufficient evidence and a need for an additional VA examination.

The Board has determined that there is no evidence to support a service connection claim for the claimed disabilities, and thus the claims are denied.

The Board denied service connection for tinnitus and found that new and material evidence had not been submitted to reopen the claim of ulnar nerve compression/ulnar neuropathy. The rating for left shoulder disability was also denied.

The veteran's appeal has been withdrawn prior to a decision being made by the Board.

The veteran's service-connected disabilities have rendered him unable to independently perform daily functions of self-care and protect himself from the hazards and dangers incident to his daily environment, warranting special monthly compensation based on need for regular aid and attendance starting September 28, 2005.

The Board found that the veteran's bilateral hearing loss and tinnitus are related to his military service, while his bronchial asthma, peripheral neuropathy of the upper and lower extremities, and degenerative disorders of the lumbar spine are not service-connected.

The Board has determined that the veteran does not have peripheral neuropathy and therefore service connection cannot be granted.

The Board denied the veteran's claims for increased ratings for diabetes mellitus, peripheral neuropathy in both lower extremities, diabetic retinopathy with cataracts, and hypertension. The evidence did not meet the criteria for a higher rating under any applicable diagnostic codes.